Controladora Vuela Compania de Aviacion S.A.B. de C.V. ADS
Controladora Vuela Compania de Aviacion S.A.B. de C.V. ADS (VLRS) Financials Nov 14, 2014, 4:01 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Controladora Vuela Compania de Aviacion S.A.B. de C.V. ADS
Fiscal year is January-December. All values MXN millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 5.05B 6.78B 8.88B 11.69B 13B
Cost of Goods Sold (COGS) incl. D&A 4.17B 5.44B 8.26B 10.32B 11.85B
COGS excluding D&A 4.13B 5.37B 8.16B 10.11B 11.55B
Depreciation & Amortization Expense 45.93M 61.69M 102.98M 211M 301.53M
Depreciation - 44.9M 82.92M 187.13M 269.35M
Amortization of Intangibles - 16.8M 20.06M 23.87M 32.18M
Gross Income 873.95M 1.34B 616.31M 1.36B 1.15B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 643.85M 712.36M 908.86M 888.4M 907.23M
Research & Development - - - - -
Other SG&A 643.85M 712.36M 908.86M 888.4M 907.23M
Other Operating Expense 0 118.87M 153.21M 152.05M 0
Unusual Expense 0 - - - 29.42M
EBIT after Unusual Expense 0 - - - (29.42M)
Non Operating Income/Expense 75.43M (59.44M) 182.92M (41.11M) 165.9M
Non-Operating Interest Income 4.82M 5.09M 5.54M 13.61M 24.77M
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 86.86M 52.22M 57.72M 89.73M 125.74M
Gross Interest Expense 86.86M 62.25M 85.82M 154.18M 150.93M
Interest Capitalized - 10.03M 28.1M 64.45M 25.2M
Pretax Income 223.49M 404.43M (315.01M) 206.8M 282.84M
Income Tax 2.22M (238.68M) 476,000 3.48M 17.55M
Income Tax - Current Domestic - - - - -
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic - - - - -
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - - 0
Equity in Affiliates - - - - 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 221.27M 643.11M (315.49M) 203.32M 265.29M
Minority Interest Expense 24.62M 70.88M (21.95M) (11.92M) (3.39M)
Net Income 196.66M 572.23M (293.54M) 215.24M 268.68M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 196.66M 572.23M (293.54M) 215.24M 268.68M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 196.66M 572.23M (293.54M) 215.24M 268.68M
EPS (Basic) - 2.64 (1.36) 1.30 0.31
Basic Shares Outstanding - 216.47M 216.47M 165.26M 865.58M
EPS (Diluted) - 2.64 (1.36) 1.30 0.31
Diluted Shares Outstanding - 216.47M 216.47M - 865.58M
EBITDA 276.03M 572.69M (342.77M) 535.03M 548.86M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
High Stakes and Deep Insights Await in Houston Cracking the nut of lower-middle market transactions ain’t a walk in the park. M&A Source®'s Fall 2026 Conference is gearing up to address the very dramas that lurk behind the scenes. Kicking off November 2-4 at the opulent JW Marriott in Houston, Texas, the event is looking to assemble a heavyweight lineup of...
Continue Reading
A Mess That Investors Can't Ignore If you're holding onto Endava plc shares, you've probably felt that gut-punch lately. Yeah, things are getting heated with a class action lawsuit alleging the company played fast and loose with its accounting practices. The complaint's about some shady dealings that may have thrown off investors' perceptions. The Core Allegations This...
Continue Reading
Big Moves in Immuno-Oncology: Astellas' Latest Bet You hear 'immuno-oncology,' you think breakthrough, right? Well, friends, that's what Astellas and Audax Biosciences are shooting for with their fresh handshake over DAX-044. On October 27, 2026, in Tokyo and Melbourne, the two outfits announced they're joining forces to bring this novel immunotherapy to the table. It's...
Continue Reading
A Major Step Forward in AI Infrastructure When two heavyweights clash, you better believe folks are paying attention. OneQode’s deal with AdaniConneX is like a shot across the bow in the AI infrastructure arena. They’re not just dipping a toe in India’s tech waters; they’re diving headfirst with 14 MW of data center muscle right there in Siruseri Sipcot, Chennai....
Continue Reading
A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...
Continue Reading
A New Twist in Illinois: Cash Pop's Arrival Here's something fresh off the press: the Illinois Lottery is now on the ride with Brightstar's Cash Pop. This patented game isn't just another number pick—it's an engaging draw-based game featuring hourly draws with price tags of $1, $2, $5, and $10. It's like clockwork, and trust me, it's more than just the usual spin....
Continue Reading
Etisalat's Stellar Performance: A Deeper Dive When a company like Etisalat drops news of a whopping 46% increase in net profit year-over-year, you sit up and pay attention. Those numbers aren’t just a flash in the pan; they're the result of some serious strategic maneuvers and ripe market conditions. Etisalat isn't resting on its laurels, and their latest financials...
Continue Reading
Amgen's Steady Dividend: A Testament to Stability Diving into the mess that is today's biotech market, Amgen (NASDAQ:AMGN) stands out like a beacon of stability with its recent dividend announcement. The Board's decision to dole out a $2.52 per share dividend for the fourth quarter of 2026 showcases confidence amidst both promising ventures and looming uncertainties....
Continue Reading
A Meeting of Great Minds in Shanghai Alright, listen up. Shanghai's gearing up to be the nerve center for the 2026 World Laureates Forum (WLF), and it's seething with potential. This ain't your regular science fair; it's a lion's den of brainpower set to crack open the future of science and tech. With the heavy-hitters like Nobel and Turing laureates on the docket, you're...
Continue Reading
Dive into Mercado González's Cultural Opening Over in La Habra, Northgate González Market has just flung open the doors to its latest masterpiece: Mercado González. Picture this, a place where the mundanity of grocery shopping melds with a vibrant fiesta of Mexican cuisine, artisanry, and cultural vibes. They transformed an older store into something that commands not...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding Exelon's Upcoming Earnings Report Exelon Corporation (NASDAQ: EXC) is preparing to reveal its quarterly earnings in the near future. Investors are keenly awaiting the results, as they want insights into the company’s performance and projections for the following period. Analysts predict that Exelon will report an earnings per share (EPS) of $0.39,...
Continue Reading
Vallourec Invites Warrant Holders to General Meeting Vallourec has announced a significant upcoming event for its warrant holders, also known as BSA. This meeting is set to take place soon, providing an opportunity for holders to engage with the company's future decisions. Details of the Meeting The general meeting will occur at the Vallourec headquarters, where the...
Continue Reading
Pomerantz LLP Begins Investigation on Behalf of Molina Investors Pomerantz LLP has embarked on an investigation focusing on the interests of investors in Molina Healthcare, Inc. (NYSE: MOH). This inquiry aims to ascertain whether Molina and certain executives may have been involved in any unlawful activities related to securities fraud. Key Financial Findings and Investor...
Continue Reading
Unlocking E-commerce Potential in Grocery Retail In a transformative announcement, SymphonyAI, a leader in predictive and generative AI SaaS products for enterprises, has unveiled groundbreaking insights from its annual grocery e-commerce study. This research indicates a noteworthy 8% growth opportunity for retailers leveraging AI-driven strategies in their connected...
Continue Reading
Honda and Nissan's Strategic Talks Honda (NYSE:HMC) and Nissan (OTC:NSANY) have entered discussions that may lead to a potential merger, a significant move reflecting the shifting landscape of Japan's automotive industry. As these two giants explore deeper ties, it marks a notable strategy to face the competition posed by Tesla and various Chinese car manufacturers....
Continue Reading